However, the proportion was lower than that in another study using data from the Korea National Health and Nutrition Examination Survey between 2016 and 2018, which reported that the proportion of DM patients receiving treatment with oral antidiabetes agents or insulin was approximately 60% (9). This evidence concerns the gene INS and diabetes mellitus.